Table 3.
Comparison of Mouse and Rat 6 Hz Pharmacology for ASDs Acting on Na+ Channels
Compound | ED50 and PI | ||||
---|---|---|---|---|---|
Mechanism of Action | Mouse Stimulus Intensity | Rat Stimulus Intensity | |||
1.5×CC97 (32mA) | 2×CC97 (44mA) | 1.5×CC97 | 2×CC97 | ||
Carbamazepine | Blocks fast inactivation | 23.7 (18.3–26.3) PI 1.9 | 38.2 (25.8–69.0) PI 1.2 | >40 PI<0.9 |
>40 PI<0.9 |
Eslicarbazepine | Blocks fast inactivation | 60.7 (46.1–72.4) PI 1.6 |
77.6 (61.3–92.4) PI 1.3 |
>200 PI n.c. |
>200 PI n.c. |
Lacosamide | Enhance slow inactivation | 10.0 (7.7–12.8) PI 2.7 |
12.9 (9.8–18.2) PI 2.1 |
15.6 (6.3–30.0) PI 0.8 |
>50 PI<0.3 |
Lamotrigine | Blocks fast inactivation | 19.5 (12.9–30.8) PI 1.5 |
43.4 (33.0–52.2) PI 0.7 |
>60 PI<0.4 |
>60 PI<0.4 |
Phenytoin | Blocks fast inactivation | 37.5 (30.1–52.7) PI 1.3 |
44.6 (38.2–48.9) PI 1.1 |
30.7a PI 0.5 |
>100 PI<0.2 |
Rufinamide | Enhance slow inactivation | 23.1 (16.8–34.0) PI >2.0 |
32.9 (23.2–39.5) PI >1.4 |
42.7 (30.2–59.5) PI 8.2 |
n.c.b |
not calculated (n.c.); Protective Index (PI; TD50/ED50)
95% CI exceeded the dose range tested
Partial efficacy (50–65% efficacy) observed at doses of 80–200 mg/kg; reduced activity observed at a dose of 350 mg/kg
N=6–8 per group, 100–120g